title: Widespread use of complementary and alternative medicine among non-Hodgkin lymphoma survivors.
abstract: There are few studies examining complementary and alternative medicine (CAM) use and beliefs among non-Hodgkin lymphoma (NHL) survivors. Seven hundred and nineteen patients with NHL from the University of Iowa/Mayo Clinic Molecular Epidemiology Resource who completed the 3-year post-diagnosis questionnaire were included in this study. Altogether 636 (89%) reported ever using CAM, with 78% utilizing vitamins, 54% alternative therapies and 45% herbals. Female gender was associated with increased overall CAM use (p=0.0001) as well as use of vitamins (p=0.0001), herbals (p=0.006) and alternative therapy (p=0.0002) for cancer. Older age (>60) was associated with increased vitamin use (p=0.005) and decreased herbal use (p=0.008). Among users, 143 (20%) believed CAM assists healing, 123 (17%) believed CAM relieves symptoms, 122 (17%) believed CAM gives a feeling of control, 110 (15%) believed CAM assists other treatments, 108 (15%) believed CAM boosts immunity, 26 (4%) believed CAM cures cancer and 36 (5%) believed CAM prevents the spread of cancer.
authors.affiliation: Department of Emergency Medicine and the Center for Health Equity and Quality Research, University of Florida Jacksonville , Jacksonville, FL , USA.
authors.forename: Sarah
authors.initials: S
authors.lastname: Rausch Osian
authors.forename: Alexis D
authors.initials: AD
authors.lastname: Leal
authors.forename: Cristine
authors.initials: C
authors.lastname: Allmer
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Maurer
authors.forename: Grezegorz
authors.initials: G
authors.lastname: Nowakowski
authors.forename: David J
authors.initials: DJ
authors.lastname: Inwards
authors.forename: William R
authors.initials: WR
authors.lastname: Macon
authors.forename: Shawna L
authors.initials: SL
authors.lastname: Ehlers
authors.forename: George J
authors.initials: GJ
authors.lastname: Weiner
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Habermann
authors.forename: James R
authors.initials: JR
authors.lastname: Cerhan
authors.forename: Carrie A
authors.initials: CA
authors.lastname: Thompson
mesh_terms: D000367:Age Factors; D000368:Aged; D000529:Complementary Therapies / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D012737:Sex Factors; D011795:Surveys and Questionnaires; D017741:Survivors / Q000706:statistics & numerical data*
keywords: Complementary therapies; lymphoma; neoplasms; survivors; vitamins
references.citation: Cancer. 2004 May 15;100(10):2253-60
references.pmid: 15139072
references.citation: Ther Drug Monit. 2007 Dec;29(6):679-86
references.pmid: 18043467
references.citation: Support Care Cancer. 2011 Apr;19(4):521-9
references.pmid: 20336329
references.citation: J Clin Oncol. 2004 Dec 1;22(23):4810-5
references.pmid: 15570083
references.citation: J Clin Oncol. 1991 Jun;9(6):1004-11
references.pmid: 2033413
references.citation: JAMA. 1998 Nov 11;280(18):1569-75
references.pmid: 9820257
references.citation: Support Care Cancer. 2002 Apr;10(3):237-46
references.pmid: 11904789
references.citation: Bone Marrow Transplant. 2007 Oct;40(8):793-800
references.pmid: 17704795
references.citation: J Clin Nurs. 2005 Jan;14(1):51-5
references.pmid: 15656848
references.citation: Rev Saude Publica. 2008 Feb;42(1):158-64
references.pmid: 18200356
references.citation: Br J Cancer. 2004 Jan 26;90(2):408-13
references.pmid: 14735185
references.citation: Complement Ther Clin Pract. 2007 May;13(2):110-5
references.pmid: 17400146
references.citation: Support Care Cancer. 2009 Jan;17(1):47-52
references.pmid: 18458963
references.citation: Altern Ther Health Med. 2003 Nov-Dec;9(6):70-4
references.pmid: 14618861
references.citation: Complement Ther Clin Pract. 2005 May;11(2):105-10
references.pmid: 15955292
references.citation: Support Care Cancer. 2005 Nov;13(11):912-9
references.pmid: 15856334
references.citation: Pain. 1995 Nov;63(2):189-198
references.pmid: 8628584
references.citation: Pharmacoepidemiol Drug Saf. 2002 Dec;11(8):671-6
references.pmid: 12512243
references.citation: Leuk Lymphoma. 2014 Apr;55(4):841-7
references.pmid: 23829282
references.citation: J Clin Oncol. 2010 Sep 20;28(27):4191-8
references.pmid: 20713849
references.citation: Natl Health Stat Report. 2008 Dec 10;(12):1-23
references.pmid: 19361005
references.citation: Semin Oncol. 2002 Dec;29(6):531-45
references.pmid: 12516036
references.citation: J Adv Nurs. 1993 May;18(5):701-6
references.pmid: 8514925
references.citation: Integr Cancer Ther. 2005 Dec;4(4):294-300
references.pmid: 16282506
references.citation: Public Health. 2010 Apr;124(4):232-7
references.pmid: 20363486
references.citation: Support Care Cancer. 2005 Oct;13(10):806-11
references.pmid: 15711946
references.citation: Hematol Oncol Clin North Am. 2008 Aug;22(4):581-617, vii
references.pmid: 18638690
references.citation: Am J Hematol. 2009 Dec;84(12):795-8
references.pmid: 19894247
references.citation: J Clin Oncol. 2000 Jul;18(13):2505-14
references.pmid: 10893280
references.citation: J Clin Oncol. 2006 Nov 10;24(32):5117-24
references.pmid: 17093273